Novotech, an Asia-Pacific biotech specialist CRO, has acquired U.S. CRO NCGS as part of its expansion program, and can now offer its biotech clients clinical services in the U.S. to support later phase global studies.   NCGS, established in 1984 in South Carolina, is a privately held CRO with a biopharma client base and a workforce of about 300 professionals across the U.S.   Novotech serves biotechs globally, leveraging deep relationships built with hundreds of Asia-Pacific sites over the l...